-
Latest News
- Energy systems & pacing in ME/CFS
- DNA Methylation & BDNF expression account for symptoms & widespread hyperalgesia in patients with CFS & FM
- Protective effect of hemin against experimental CFS in mice: possible role of neurotransmitters
- Post-viral fatigue and COVID-19: lessons from past epidemics
- Preliminary ICF core set for patients with ME/CFS in rehabilitation medicine
Archives
Tag Archives: Jon D Kaiser
KPAX002 as a treatment for ME/CFS – disappointing trial results
Research abstract: KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a prospective, randomized trial, by Jose G Montoya, Jill N Anderson, Danya L Adolphs, Lucinda Bateman, Nancy Klimas, Susan M Levine, Donn W Garvert, Jon D Kaiser … Continue reading →
Posted in News
|
Tagged Danya L Adolphs, Donn W Garvert, Dr Jose Montoya, Dr Lucinda bateman, Dr Nancy Klimas, Dr Susan Levine, hypometabolic disorder, Jill Anderson, Jon D Kaiser, KPax Synergy trial, KPAX002, methylphenidate hydrochloride, mitochondrial dysfunction
|
Comments Off on KPAX002 as a treatment for ME/CFS – disappointing trial results
